Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Cancer Genomics & Proteomics
    • Anticancer Research
    • In Vivo

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Cancer Genomics & Proteomics
  • Other Publications
    • Cancer Genomics & Proteomics
    • Anticancer Research
    • In Vivo
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Cancer Genomics & Proteomics

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
  • About Us
    • General Policy
    • Contact
  • Visit iiar on Facebook
  • Follow us on Linkedin
Research ArticleArticles

Mapping Proteome Changes in Microsatellite Stable, Recurrent Colon Cancer Reveals a Significant Immune System Signature

MAGNUS BERLE, KJERSTI E. HESTETUN, HEIDRUN VETHE, SIMONA CHERA, JOAO A. PAULO, OLAV DAHL and METTE PERNILLE MYKLEBUST
Cancer Genomics & Proteomics March 2022, 19 (2) 130-144; DOI: https://doi.org/10.21873/cgp.20309
MAGNUS BERLE
1Department of Clinical Medicine, University of Bergen, Bergen, Norway;
2Department of Surgery, Haukeland University Hospital, Bergen, Norway;
3Department of Surgery, Haraldsplass Deaconess Hospital, Bergen, Norway;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: magnus.berle{at}uib.no
KJERSTI E. HESTETUN
4Department of Clinical Science, University of Bergen, Bergen, Norway;
5Department of Oncology and Medical Physics, Haukeland University Hospital, Bergen, Norway;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
HEIDRUN VETHE
1Department of Clinical Medicine, University of Bergen, Bergen, Norway;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
SIMONA CHERA
4Department of Clinical Science, University of Bergen, Bergen, Norway;
6Department of Medicine, Division of Endocrinology, Diabetes, Nutrition and Patient Education, University Hospital of Geneva, Geneva, Switzerland;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
JOAO A. PAULO
7Department of Cell Biology, Harvard Medical School, Boston, MA, U.S.A.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
OLAV DAHL
4Department of Clinical Science, University of Bergen, Bergen, Norway;
5Department of Oncology and Medical Physics, Haukeland University Hospital, Bergen, Norway;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
METTE PERNILLE MYKLEBUST
5Department of Oncology and Medical Physics, Haukeland University Hospital, Bergen, Norway;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Information

vol. 19 no. 2 130-144
DOI 
https://doi.org/10.21873/cgp.20309
PMID 
35181583

Published By 
International Institute of Anticancer Research
Print ISSN 
1109-6535
Online ISSN 
1790-6245
History 
  • Received December 21, 2021
  • Revision received January 10, 2022
  • Accepted January 12, 2022
  • Published online February 18, 2022.

Copyright & License 
Copyright © 2022 The Author(s). Published by the International Institute of Anticancer Research.

Author Information

  1. MAGNUS BERLE1,2,3⇑,
  2. KJERSTI E. HESTETUN4,5,
  3. HEIDRUN VETHE1,
  4. SIMONA CHERA4,6,
  5. JOAO A. PAULO7,
  6. OLAV DAHL4,5 and
  7. METTE PERNILLE MYKLEBUST5
  1. 1Department of Clinical Medicine, University of Bergen, Bergen, Norway;
  2. 2Department of Surgery, Haukeland University Hospital, Bergen, Norway;
  3. 3Department of Surgery, Haraldsplass Deaconess Hospital, Bergen, Norway;
  4. 4Department of Clinical Science, University of Bergen, Bergen, Norway;
  5. 5Department of Oncology and Medical Physics, Haukeland University Hospital, Bergen, Norway;
  6. 6Department of Medicine, Division of Endocrinology, Diabetes, Nutrition and Patient Education, University Hospital of Geneva, Geneva, Switzerland;
  7. 7Department of Cell Biology, Harvard Medical School, Boston, MA, U.S.A.
  1. Correspondence to: Magnus Berle, University of Bergen, Department of Clinical Medicine, Pb 7804, 5020 Bergen, Norway. Tel: +47 98042039, e-mail: magnus.berle{at}uib.no
View Full Text

Statistics from Altmetric.com

Cited By...

  • Citations
  • Google Scholar

This article has not yet been cited by articles in journals that are participating in Crossref Cited-by Linking.

PreviousNext
Back to top

In this issue

Cancer Genomics - Proteomics: 19 (2)
Cancer Genomics & Proteomics
Vol. 19, Issue 2
March-April 2022
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Back Matter (PDF)
  • Ed Board (PDF)
  • Front Matter (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Cancer Genomics & Proteomics.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Mapping Proteome Changes in Microsatellite Stable, Recurrent Colon Cancer Reveals a Significant Immune System Signature
(Your Name) has sent you a message from Cancer Genomics & Proteomics
(Your Name) thought you would like to see the Cancer Genomics & Proteomics web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
11 + 4 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
Mapping Proteome Changes in Microsatellite Stable, Recurrent Colon Cancer Reveals a Significant Immune System Signature
MAGNUS BERLE, KJERSTI E. HESTETUN, HEIDRUN VETHE, SIMONA CHERA, JOAO A. PAULO, OLAV DAHL, METTE PERNILLE MYKLEBUST
Cancer Genomics & Proteomics Mar 2022, 19 (2) 130-144; DOI: 10.21873/cgp.20309

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Reprints and Permissions
Share
Mapping Proteome Changes in Microsatellite Stable, Recurrent Colon Cancer Reveals a Significant Immune System Signature
MAGNUS BERLE, KJERSTI E. HESTETUN, HEIDRUN VETHE, SIMONA CHERA, JOAO A. PAULO, OLAV DAHL, METTE PERNILLE MYKLEBUST
Cancer Genomics & Proteomics Mar 2022, 19 (2) 130-144; DOI: 10.21873/cgp.20309
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Materials and Methods
    • Results
    • Discussion
    • Conclusion
    • Acknowledgements
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

Cited By...

  • Identification and Validation of the Glycolysis and Immune-related Gene Signature for Prognosis in Colorectal Cancer
  • Google Scholar

More in this TOC Section

  • High Expression of PKCζ And CTNNBIP1 Is Associated With Poor Prognosis in Luminal B Breast Cancer
  • Particulate Matter 2.5 Induces FGFR1-mediated Integrin Switch to Promote Non-small Cell Lung Cancer Metastasis
  • Noggin Promotes Cell Proliferation Through Up-regulating EGFR/HER2 in Pancreatic Cancer Cells
Show more Articles

Keywords

  • Colon cancer
  • microsatellite stable
  • recurrence
  • proteomics
  • immune system
Cancer & Genome Proteomics

© 2026 Cancer Genomics & Proteomics

Powered by HighWire